Our breakthrough non-melanoma skin cancer product is now owned by a world leader in dermatology.
Photocure developed and commercialized a product for non-melanoma skin cancer and actinic keratosis, based on Photocure Technology®. Only affected tissue is removed, while leaving normal tissue unharmed. The product was divested to Galderma S.L in 2009.
Photocure developed a breakthrough photodynamic cosmetic product specifically formulated to improve the overall appearance of skin, visibly reduce the outward signs of aging and minimize the appearance of pores. The product was sold to Bellus Medical in 2017.